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Abstract 
We report, in full, two 3-step syntheses of (S)-aspartate semi-aldehyde, an important synthetic 
and biosynthetic precursor, from diprotected aspartic acid. The first synthesis proceeds via a 
thioester, the second via a Weinreb amide. Each route yields pure (S)-aspartate semi-aldehyde in 
excellent yield. The utility of (S)-aspartate semi-aldehyde prepared in this manner was 
demonstrated with an inhibition study of dihydrodipicolinate synthase, wherein ∆2-
tetrahydroisophthalic acid is shown to be a non-competitive inhibitor with respect to both 
substrates. 
 






The lysine biosynthesis pathway has remained a target for therapeutic agents for many years, 
although no commercial product has yet been shown to inhibit this pathway.1,2 The enzyme that 
catalyses the branchpoint of the diaminopimelate pathway to lysine is dihydrodipicolinate 
synthase (DHDPS). Despite intense scrutiny over many years, no potent inhibitor of this pathway 
has yet been found. DHDPS catalyses the condensation of (S)-aspartate semi-aldehyde (ASA, 1) 
and pyruvate (2) to form an unstable heterocycle, formally thought to be dihydrodipicolinate, but 
now believed to be 4-hydroxytetrahydrodipicolinate (3) (Scheme 1).2 (S)-ASA is drawn here as 
the aldehyde, but is actually thought to exist predominantly in the hydrated form.3,4 
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Scheme 1. The condensation of pyruvate and (S)-ASA to form 4-hydroxytetrahydrodipicolinate, 
catalyzed by DHDPS. 
 
For detailed biochemical analysis of this reaction, a convenient source of pure (S)-ASA is 
required.1 In particular, for screening of inhibitors of potential therapeutic use, the ASA 
employed must be free of impurities that may inhibit the enzyme and confuse the results. 
Enantiomerically pure ASA derivatives are also increasingly important synthetic intermediates, 
as the aldehyde moiety can be functionalized to yield more complex structures. The potential 
access to a variety of polyfunctional non-proteinogenic and unnatural amino acids using ASA 
and its derivatives has already been demonstrated.2 ASA manipulation has also proved to be 
important in the synthesis of pharmaceuticals, aroma and flavour chemicals, pesticides and 
herbicides, dyes and pigments.5  
ASA is difficult to synthesize and characterize since, like many amino aldehydes, it has a 
marked tendency to polymerize and is only stable in aqueous strong acid.3-5 There are three 
methods for synthesizing (S)-ASA that are commonly used for biochemical studies.3,6,7 The later 
methods3,7are derived from the original method of Black and Wright6 which requires the 
ozonolysis of (S)-allylglycine. Other methods have also been reported in the literature, which 
yield either free ASA or diprotected ASA, but they are often complex multi-step procedures 
and/or are extremely low yielding procedures and have not been widely adopted.4,8,9  
In the original synthesis of (S)-ASA, the aldehyde moiety was obtained by oxidative cleavage 
of the double bond of (S)-allylglycine by ozonolysis.6 The reaction is carried out in a 1 M 
aqueous hydrochloric acid solution at 0°C, with ozone bubbled through the solution. The 
reported yield of the desired product is 90-100%, as determined by an enzymatic assay following 
the conversion of ASA into homoserine by homoserine dehydrogenase.6 However, (S)-ASA 
produced by this method has been found to have variable purity and no chemical characterization 
of the product has ever been reported.3,4 This method is still commonly used today, presumably 
due to the one step procedure from allylglycine.10-12 However, studies in our laboratory using the 
DHDPS/DHDPR coupled enzymatic assay7 have suggested that the ozonolysis product is 
contaminated by material that has an inhibitory effect on the DHDPS enzyme.13 
To address the deficiencies of the Black and Wright method, Tudor and coworkers have 
investigated the ozonolysis of (S)-N-tert-butoxycarbonyl allyglycine p-methoxybenzyl ester.3 
Removal of the protecting groups with TFA affords the hydrate of ASA as a trifluoroacetate salt 
4, which can be stored for many months at 0 °C as a stable solid. This method has since been 
modified so that a Lemieux-Johnson oxidation is used in place of the ozonolysis.7 In our hands, 
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the overall yield of the latter method for the preparation of (S)-ASA was 59%, an increase on 
previously reported values of 42% and 43%.3 However, the route is multi-step, involves several 
purifications, and is particularly tedious for those focusing on biochemical studies of DHDPS. 
We report herein, in full detail, two convenient syntheses of (S)-ASA from commercially 
available α-tert-butyl (S)-N-tert-butoxycarbonyl aspartate (5).14 Literature procedures were 
employed to activate the aspartic acid side chain, firstly, to a thio-ester15 and secondly, to a 
Weinreb amide.16 We also demonstrate the utility of the synthesis in a kinetic analysis of 
inhibition by ∆2-tetrahydroisophthalic acid. 
 
 
Results and Discussion 
 
Synthesis of (S)-ASA 
In the first synthesis, α-tert-butyl (S)-N-tert-butoxycarbonyl aspartate (5) in dichloromethane was 
reacted with DCC, ethanethiol and DMAP at room temperature. Purification was achieved by 
flash chromatography yielding the thioester 6 as a clear oil in 94% yield. Reduction of the 
thioester to the aldehyde 7 was achieved in 84% yield using triethylsilane/10% Pd/C. The 
method of Tudor and coworkers3 was used to deprotect the aldehyde 7 by stirring in 
trifluoroacetic acid in dry dichloromethane, with (S)-ASA being isolated as the hydrated 
trifluoroacetate salt 4, as a pale yellow solid, in 96% yield.  
This procedure involves only three steps and was relatively simple, cutting out the need to 
use osmium tetroxide (not previously mentioned). The overall reaction yield was 75% and the 
purity of the ASA produced was also of a very high standard, as determined by the 
DHDPS/DHDPR coupled enzymatic assay (99%). The only drawback of this method is that 
there are two purification steps required.  
In a bid to cut down the number of purification steps required, the procedure of Wernic and 
coworkers was investigated as an alternative to obtaining (S)-ASA (Scheme 2).16 α-tert-Butyl 
(S)-N-tert-butoxycarbonyl aspartate (5) was converted to the corresponding Weinreb amide 8 in 
excellent yield (86%), using N,O-dimethylhydroxylamine hydrochloride, (benzotriazol-1-
yloxy)tris(dimethylamino) phosphonium hexafluorophosphate (BOP.PF6), and triethylamine. 
The resulting product 8 was reduced with diisobutyl aluminium hydride at –78 °C to give 
aldehyde 7 in 95% yield, which required no further purification. The method of Tudor3 was 
again used to deprotect the aldehyde 7 to afford (S)-ASA as the hydrated trifluoroacetate salt 4 in 
96% yield. This procedure was a much faster and easier method for obtaining (S)-ASA than the 
oxidation of diprotected (R,S)-allyglycine by osmium tetroxide/periodate or by ozonolysis.6  
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Scheme 2. Three step syntheses of (S)-ASA via either the thioester or Weinreb amide. (i) DCC, 
EtSH, DMAP, CH2Cl2 (94%); (ii) BOP.PF6, Et3N, CH3ONHCH3.HCl, CH2Cl2 (86%); (iii) 
Et3SiH/10% Pd/C, CH2Cl2 (84%); (iv) DIBAL/THF –78oC (95%); (v) CF3CO2H (96%). 
 
The overall yield of the reaction from the diprotected aldehyde 5 was also greatly increased 
(82%) when compared to other literature procedures.3 The sequence has routinely been carried 
out on a 2 millimole scale. The above procedure is only three steps to the pure aldehyde and only 
one purification step is required. The purity of the ASA generated was also of a very high 
standard (99%) as checked by the coupled assay of DHDPS and DHDPR. No evidence of 
contaminating inhibitory compounds was found. 
 
Inhibition of DHDPS by ∆2-tetrahydroisophthalic acid 
∆2-Tetrahydroisophthalic acid is a product mimic of the DHDPS reaction product (Scheme 3). In 
the literature, ∆2-tetrahydroisophthalic acid has been reported to be a weak inhibitor of DHDPS.7 
To date, no detailed kinetic studies have been done to determine the type of inhibition. 
 







Scheme 3. Structure of ∆2-tetrahydroisophthalic acid compared to 4-hydroxy-2,3,4,5-
tetrahydrodipicolinate. 
Issue in Honor of Prof. Rod Rickards ARKIVOC 2004 (x) 166-177 
ISSN 1424-6376 Page 170 ©ARKAT USA, Inc 
Inhibition kinetics of ∆2-tetrahydroisophthalic acid with respect to ASA and pyruvate were 
carried out according to previously described methods,13 with ∆2-tetrahydroisophthalic 
concentrations being varied between 1 and 30 mM. The kinetic data were fitted to mathematical 
models using the Enzfitter computer program that simulated competitive, noncompetitive, 
uncompetitive and mixed inhibition patterns to determine the best fit and inhibition constant Ki. 
Lineweaver-Burk and Eadie-Hofstee plots were used to show the quality of the generated data. 
The inhibition was found to be noncompetitive with respect to both substrates, ASA and 
pyruvate. The Ki for ASA was found to be in the range of (24 – 31) mM, while the Ki of 
pyruvate was found to be in the range of (22 – 28) mM (Figures 4-7). These data suggest that ∆2-
tetrahydroisophthalic acid does not bind at the active site, which explains the weak inhibition 
observed. The high quality of the data generated in all cases confirms the utility of (S)-ASA 
generated by these methods for kinetic study. 
 
Legend 
1. [Delta 2- tetrahydroisophthalic acid] = 0.0 mM 
3. [Delta 2- tetrahydroisophthalic acid] = 5.0 mM 
5. [Delta 2- tetrahydroisophthalic acid] = 15  mM 
2. [Delta 2- tetrahydroisophthalic acid] = 1.0 mM 
4. [Delta 2- tetrahydroisophthalic acid] = 10  mM 
6. [Delta 2- tetrahydroisophthalic acid] = 30  mM 
 
Figure 4. Lineweaver-Burk plot of DHDPS with respect to ASA at different ∆2-
tetrahydroisophthalic acid concentrations. (R2 = 0.985, P< 0.05). 
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Legend 
1. [Delta 2- tetrahydroisophthalic acid] = 0.0 mM 
3. [Delta 2- tetrahydroisophthalic acid] = 5.0 mM 
5. [Delta 2- tetrahydroisophthalic acid] = 15  mM 
2. [Delta 2- tetrahydroisophthalic acid] = 1.0 mM 
4. [Delta 2- tetrahydroisophthalic acid] = 10  mM 
6. [Delta 2- tetrahydroisophthalic acid] = 30  mM 
 
Figure 5. Eadie-Hofstee plot of DHDPS with respect to ASA at different ∆2-
tetrahydroisophthalic acid concentrations. (R2 = 0.985, P< 0.05). 
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Legend 
1. [Delta 2- tetrahydroisophthalic acid] = 0.0 mM 
3. [Delta 2- tetrahydroisophthalic acid] = 5.0 mM 
5. [Delta 2- tetrahydroisophthalic acid] = 15  mM 
2. [Delta 2- tetrahydroisophthalic acid] = 1.0 mM 
4. [Delta 2- tetrahydroisophthalic acid] = 10  mM 
6. [Delta 2- tetrahydroisophthalic acid] = 30  mM 
 
Figure 6. Lineweaver-Burk plot of DHDPS with respect to pyruvate at different ∆2-
tetrahydroisophthalic acid concentrations. (R2 = 0.983, P< 0.05). 
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Legend 
1. [Delta 2- tetrahydroisophthalic acid] = 0.0 mM 
3. [Delta 2- tetrahydroisophthalic acid] = 5.0 mM 
5. [Delta 2- tetrahydroisophthalic acid] = 15  mM 
2. [Delta 2- tetrahydroisophthalic acid] = 1.0 mM 
4. [Delta 2- tetrahydroisophthalic acid] = 10  mM 
6. [Delta 2- tetrahydroisophthalic acid] = 30  mM 
 
Figure 7. Eadie-Hofstee plot of DHDPS with respect to pyruvate at different ∆2-
tetrahydroisophthalic acid concentrations. (R2 = 0.983, P< 0.05). 
 
In conclusion, (S)-ASA has been synthesized from commercially available α-tert-butyl (S)-
N-tert-butoxycarbonyl aspartate (5) in three steps via side-chain activation with an overall yield 
of 82%. This represents a significant advance over previously published routes to (S)-ASA and is 
the preferred synthetic route to (S)-ASA for future biochemical investigations.1,13,20 The utility of 
(S)-aspartate semi-aldehyde prepared in this manner was demonstrated with an inhibition study 
of dihydrodipicolinate synthase, wherein ∆2-tetrahydroisophthalic acid is shown to be a non-
competitive inhibitor with respect to both substrates. 
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Experimental Section 
 
General Procedures. Starting materials were obtained from Aldrich Chemicals, (Sigma 
Chemical) Company Ltd (Castle Hill, Australia.) Unless otherwise stated, all synthetic reactions 
were performed in dry glassware under an atmosphere of oxygen-free nitrogen or argon. All 
organic extracts were washed with brine and dried over anhydrous magnesium sulfate. After 
filtration of solutions to remove drying agents, the solvents were removed under reduced 
pressure. 
1H NMR spectra were recorded on either a Varian Unity 300 or Varian Inova 500 spectrometer, 
operating at 300 and 500 MHz respectively. 13C NMR spectra were obtained on either a Varian 
Unity 300 or Varian Inova 500 spectrometer, operating at 75 and 126 MHz respectively. For 1H 
NMR, all chemical shifts are reported relative to tetramethylsilane (TMS), if run in deuterated 
chloroform (CDCl3). For samples run in deuterium oxide (D2O) the spectra were referenced to 
the residual protonated solvent at 4.70 ppm, and for samples run in deuterated methanol 
(CD3OD) the spectra were referenced to the residual protonated solvent peak at 3.30 ppm. For 
13C spectra run in deuterated chloroform (CDCl3) the spectra were referenced to the residual 
protonated solvent at 77.0 ppm, and for samples run in deuterated methanol (CD3OD) the spectra 
was reference to the residual protonated solvent at 49.3 ppm. Melting points were determined 
using an electrothermal melting point apparatus and are uncorrected. 
 
α-tert-Butyl β-S-ethyl (S)-N-(tert-butoxycarbonyl) thioaspartate (6).15 To a solution of α-tert-
butyl β-(S)-ethyl (S)-N-(tert-butoxycarbonyl)aspartate (5) (135 mg, 0.467 mmol) in 
dichloromethane (1.4 mL) was added DCC (116 mg, 0.564 mmol), ethanethiol (108 µl, mmol) 
and DMAP (5.4 mg, 0.046 mmol). The reaction mixture was stirred at RT for 3 h, then filtered to 
remove the precipitate. The filtrate was evaporated and the residue was purified by flash 
chromatography on silica, using 10% ethyl acetate/petroleum ether as the eluant, to give the title 
compound (6) as a clear oil (165 mg, 94%). 1H NMR (300 MHz, CDCl3) δ 1.24 (3H, t, J = 7.2 
Hz, EtS), 1.44 (9H, s, C(CH3)3), 1.45 (9H, s, C(CH3)3), 2.95-2.8 (2H, m, EtS), 3.02 (1H, dd, J = 
5, 16 Hz, CHH’), 3.18 (1H, dd, J = 4.8, 16.5 Hz, CHH’), 4.41 (1H, m, CH), 5.39 (1H, m, NH). 
N-tert-BOC-(S)-Aspartic acid 1-(tert-butyl ester) N-methoxy-N-methylamide (8).16 
(Benzotriazol-1-yloxy)tris(dimethylamino) phosphonium hexafluorophosphate (BOP.PF6) (163 
mg, 0.380 mmol) was added to a stirred solution of N-tert-BOC-(S)-aspartic acid 1-(tert-butyl 
ester) (5) (100 mg, 0.346 mmol) and triethylamine (54 µL, 0.385 mmol) in dichloromethane (3.5 
mL) at room temperature. After 5 minutes of stirring, O,N-dimethylhydroxyamine hydrochloride 
(40 mg, 0.397 mmol) was added, followed by triethylamine (54 µL, 0.385 mmol). All solid 
material dissolved within 10 minutes and the mixture was stirred for 2 h at RT. The reaction 
mixture was washed with 1 M aqueous HCl solution (3 x 1 mL), H2O (1 x 1 mL), 1 M aqueous 
NaHCO3 solution (2 x 1 mL) and H2O (2 x 1 mL). The solvent was removed in vacuo to give a 
clear yellow oily product, which was purified by flash chromatography on silica, using 30% 
ethyl acetate/petroleum ether as the eluant, to give the title compound (8)16 as a colourless oil 
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(100 mg, 86%). 1H NMR (500 MHz, CDCl3) δ 1.44 (9H, s, -C(CH3)3), 1.46 (9H, s, -C(CH3)3), 
2.89 (2H, m, -CH2-), 3.17 (3H, s, -CH3), 3.69 (3H, s, -OCH3), 4.45 (1H, m, -CHNH-), 5.66 (1H, 
m, -NH-). 13C NMR (75 MHz, CDCl3) δ 27.88, 28.33, 29.64, 31.91, 50.35, 61.19, 79.49, 83.39, 
155.74, 169.78, 192.13. 
tert-Butyl (S)-2-[N-(tert-butoxycarbonyl)amino]-4-oxobutanoate (7).15 Method A: Triethylsilane 
(238 µL, 1.485 mmol) was quickly added to a solution of α-tert-butyl β-S-ethyl (S)-N-(tert-
butoxycarbonyl) thioaspartate (6) (165 mg, 0.495 mmol) and 10% Pd/C (10.6 mg, 0.0099 mmol) 
in dichloromethane (2 mL) cooled in an ice bath to maintain the internal temperature between 
15-20 °C. The reaction was monitored for 20 minutes, after which the temperature no longer 
increased. The reaction mixture was then filtered through celite and concentrated in vacuo. Flash 
chromatography on silica, using 15% ethyl acetate/petroleum ether as the eluant, gave tert-butyl 
(S)-2-[N-(tert-butoxycarbonyl)amino]-4-oxobutanoate (7)15 as a clear oil (114 mg, 84%). 1H 
NMR (500 MHz, CDCl3) δ 1.44 (9H, s, -C(CH3)3), 1.47 (9H, s, -C(CH3)3), 2.96 (2H, m, -CH2-), 
4.47 (1H, m, -CHNH-), 5.38 (1H, m, -NH-), 9.74 (1H, s, -COH). 13C NMR (75 MHz, CDCl3) δ 
27.79, 28.23, 46.31, 49.23, 80.02, 82.67, 155.33, 169.88, 199.40. 
Method B: A solution of diisobutylaluminum hydride (DIBAL) in hexane (1 M, 0.55 mL, 
0.55 mmol ) was added dropwise over 20 minutes to a stirred solution of N-t-BOC-(S)-aspartic 
acid 1-(tert-butyl ester) N-methoxy-N-methylamide (8) (110 mg, 0.36 mmol) in anhydrous THF 
(1.8 mL) at –78 °C. The mixture was allowed to stir at –78 °C for 2 h. The reaction mixture was 
partitioned between 0.35 M aqueous NaHSO4 solution (3.6 mL) and diethyl ether (5.5 mL). After 
separation, the aqueous layer was extracted with diethyl ether (3 x 2 mL). The combined ethereal 
layers were washed with 1 M HCl solution (3 x 1mL), 1 M aqueous NaHCO3 solution (3 x 1 
mL), and brine (3 x 1 mL). Concentration in vacuo gave 1-tert-butyl (S)-2-[N-(tert-
butoxycarbonyl)amino]-4-oxobutanoate as a colourless oil (92 mg, 95%), which solidified on 
standing at room temperature. 
(S) Aspartic acid β-semi-aldehyde hydrate trifluoroacetate. (4).7 tert-Butyl (S)-2-[N-(tert-
butoxycarbonyl)amino]-4-oxobutanoate (681 mg, 2.5 mmol) was dissolved in dry 
dichloromethane (15 mL). The reaction was stirred under argon and trifluoroacetic acid (15 mL) 
was added via a syringe. The reaction was stirred for 2 h at room temperature and developed a 
deep red colour. The solvent was then removed in vacuo to give a brown oily residue, which was 
partitioned between water (50 mL) and ethyl acetate (50 mL). Upon separation, the aqueous 
layer was washed with ethyl acetate (2 x 50 mL). The aqueous layer was then concentrated 
(using a freeze-drier) to yield (S)-aspartate-β-semi-aldehyde hydrate trifluoroacetate (4) as a pale 
yellow solid (598 mg, 96%). Purity was determined to be 99% using the coupled assay of 
DHDPS and DHDPR.7 1H NMR (500 MHz, D2O) δ 1.99 (2H, m, -CH2CHNH2), 3.98 (1H, m, -
CHNH2), 5.21 (1H, m, -CH(OH)2). 13C NMR (75 MHz, D2O) δ 36.52, 50.33, 88.04, 108.59, 
172.05. 
Methyl ∆2-tetrahydroisophthalate.17,18 Thionyl chloride (32.5 mL, 0.44 mol) was added 
dropwise to a stirred solution of dimethyl cyclohexanol 2,6–dicarboxylate17,19 (1 g, 4.63 mmol) 
in pyridine (17 mL, 0.203 mol) at 0 °C. The reaction was stirred for 30 minutes while slowly 
Issue in Honor of Prof. Rod Rickards ARKIVOC 2004 (x) 166-177 
ISSN 1424-6376 Page 176 ©ARKAT USA, Inc 
warming to room temperature. The reaction was then stirred for 1 h, before being re-cooled to 
0 °C. The reaction was quenched by the slow addition of water (45 mL). The reaction mixture 
was extracted with diethyl ether (3 x 70 mL). The combined ethereal layers were dried over 
MgSO4 and the solvent removed in vacuo to yield a colorless oil. Purification by column 
chromatography on silica, using 10% ethyl acetate/petroleum ether as the eluant gave methyl ∆2-
tetrahydroisophthalate as a colourless oil (495 mg, 54%). 1H NMR (300 MHz, CDCl3) δ 1.56 – 
1.63 (2H, m, -CH2CH2CH2-), 1.78 – 1.80 (2H, m, -CH2CHCH=), 2.24 – 2.3 (2H, m, -CH2C=), 
3.2 – 3.26 (1H, m, -CHCH=), 3.75 – 3.76 (6H, m, -OCH3), 7.02 (1H, bs, =CH-).  
∆2-Tetrahydroisophthalic acid.17,18 Methyl ∆2-tetrahydroisophthalate (200 mg, 1.01 mmol) was 
dissolved in 20% aqueous KOH solution (15 mL) and the mixture refluxed until the starting 
material disappeared (as monitored by TLC - approx. 3 h). The solution was acidified to pH 3 
with 2 M HCl solution and extracted with ethyl acetate (3 x 30 mL). The solvent was removed in 
vacuo to yield ∆2-tetrahydroisophthalic acid as a white solid (127 mg, 73%) which needed no 
further purification. 1H NMR (300 MHz, CD3OD) δ 1.52 – 1.60 (2H, m, -CH2CH2CH2-), 1.62 – 
1.80 (2H, m, -CH2CHC=), 2.15 – 2.20 (2H, m, -CH2C=), 3.19 – 3.23 (1H, m, -CH–CH=), 7.02 – 
7.03 (1H, bs, -CH=). 13C NMR (75 MHz, CD3OD) δ 22.1, 25.4, 26.0, 43.4, 133.4, 138.0, 171.0, 
177.0. 
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